Parkinson’s & Movement Disorders Clinical Trials

Sponsored Clinical Trials

Principal Investigator Initiated Studies

Recently Completed Studies

  • A Phase 3, 12-Week, Double-Blind, Placebo- and Active-Controlled Efficacy and Safety Study of Preladenant in Subjects with Moderate to Severe Parkinson’s Disease (Phase 3, Protocol No. P04938) (closed 2013)
  • A Phase 3, 40- Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects with Moderate to Severe Parkinson’s Disease (Phase 3, Protocol No. P06153) (closed 2014)
  • A Multi-Center, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic (closed 2013)
  • Magnetic Stimulation for the Treatment of Motor and Mood Symptoms of Parkinson’s Disease (closed 2015)
  • Sleep and Learn with TMS in Parkinson’s Disease (closed 2014)
  • Efficacy and Safety of ADS-5102 (Amantadine HCL) Extended Release Capsule for the Treatment of Levodopa induced Dyskinesia in Parkinson’s Disease Patients (EASE LID Study) (closed 2016)

For more information about research at the Fresco Institute, contact our research team at 646-501-4367 or PDResearch@nyumc.org.